Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
Clinical trial NCT07354100 · RECRUITING
Trial details
- NCT number
- NCT07354100
- Sponsor
- University of Chicago
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-15
- Primary completion
- 2029-04-13
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.